tradingkey.logo

DENTSPLY SIRONA Inc

XRAY

13.160USD

-0.260-1.94%
Close 09/19, 16:00ETQuotes delayed by 15 min
2.62BMarket Cap
LossP/E TTM

DENTSPLY SIRONA Inc

13.160

-0.260-1.94%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
84 / 207
Overall Ranking
186 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 17 analysts
Hold
Current Rating
16.792
Target Price
+25.12%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Overvalued
The company’s latest PE is -2.82, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 202.86M shares, decreasing 14.75% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 21.03M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.24.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 7.25, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 936.00M, representing a year-over-year decrease of 4.88%, while its net profit experienced a year-over-year decrease of 1025.00%.

Score

Industry at a Glance

Previous score
7.25
Change
0

Financials

5.59

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

5.71

Operational Efficiency

8.49

Growth Potential

8.79

Shareholder Returns

7.66

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -2.87, which is 168.40% below the recent high of -7.71 and -896.00% above the recent low of -28.61.

Score

Industry at a Glance

Previous score
2.80
Change
1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 84/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.59, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for DENTSPLY SIRONA Inc is 16.50, with a high of 24.00 and a low of 14.00.

Score

Industry at a Glance

Previous score
6.59
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 17 analysts
Hold
Current Rating
16.792
Target Price
+25.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

118
Total
7
Median
8
Average
Company name
Ratings
Analysts
DENTSPLY SIRONA Inc
XRAY
17
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 6.12, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 14.43 and the support level at 12.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.12
Change
0.03

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.105
Sell
RSI(14)
36.464
Neutral
STOCH(KDJ)(9,3,3)
8.196
Oversold
ATR(14)
0.448
Low Volatility
CCI(14)
-145.499
Sell
Williams %R
93.407
Oversold
TRIX(12,20)
-0.218
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
13.434
Sell
MA10
13.646
Sell
MA20
13.974
Sell
MA50
14.479
Sell
MA100
15.133
Sell
MA200
16.168
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 101.79%, representing a quarter-over-quarter decrease of 3.39%. The largest institutional shareholder is The Vanguard, holding a total of 21.03M shares, representing 10.54% of shares outstanding, with 4.32% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
20.63M
+2.72%
BlackRock Institutional Trust Company, N.A.
17.18M
+0.40%
First Eagle Investment Management, L.L.C.
Star Investors
14.44M
-0.42%
AQR Capital Management, LLC
6.35M
+119.38%
Fuller & Thaler Asset Management Inc.
12.08M
+4.67%
T. Rowe Price Associates, Inc.
Star Investors
13.77M
+11.32%
Lazard Asset Management, L.L.C.
9.36M
+16.38%
Cooke & Bieler, L.P.
9.16M
-0.17%
State Street Global Advisors (US)
6.73M
-0.48%
Dimensional Fund Advisors, L.P.
6.96M
+1.53%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.23, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.23
Change
0.02
Beta vs S&P 500 index
0.98
VaR
+3.31%
240-Day Maximum Drawdown
+50.34%
240-Day Volatility
+47.15%
Return
Best Daily Return
60 days
+6.13%
120 days
+16.30%
5 years
+16.30%
Worst Daily Return
60 days
-7.50%
120 days
-8.41%
5 years
-28.02%
Sharpe Ratio
60 days
-1.30
120 days
-0.38
5 years
-0.60
Risk Assessment
Maximum Drawdown
240 days
+50.34%
3 years
+70.45%
5 years
+81.88%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.25
5 years
-0.18
Skewness
240 days
-2.44
3 years
-1.80
5 years
-1.46
Volatility
Realised Volatility
240 days
+47.15%
5 years
+36.68%
Standardised True Range
240 days
+4.49%
5 years
+7.43%
Downside Risk-Adjusted Return
120 days
-60.70%
240 days
-60.70%
Maximum Daily Upside Volatility
60 days
+30.59%
Maximum Daily Downside Volatility
60 days
+25.76%
Liquidity
Average Turnover Rate
60 days
+1.54%
120 days
+1.58%
5 years
--
Turnover Deviation
20 days
+24.32%
60 days
-0.11%
120 days
+2.93%

Peer Comparison

Healthcare Equipment & Supplies
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc
XRAY
6.29 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI